Arkolith/Insider Trading/ABIO/Form 4

Janus Henderson Biotech Innovation Master Fund Ltd

10% OwnerARCA biopharma, Inc. (ABIO) · full profile →Form 4 · filed Aug 20, 2024
Net Buying
Open-Market Buys
$17K
Open-Market Sells
$0
Net Open-Market Flow
$17K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 16, 2024Buy(P)5K$2.93$16K2.1M
Aug 16, 2024Buy(P)428$2.98$1K2.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-24-027344) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML